Back
iShares S&P Mid-Cap 400 Value ETF Vs. Intra-Cellular Therapies Industry Stock Comparison
Sell
47
IJJ
iShares S&P Mid-Cap 400 Value ETF
Last Price:
123.35
Seasonality Move:
2.55%
Sell
14
ITCI
Intra-Cellular Therapies
Last Price:
73.33
Seasonality Move:
39.33%
Sell
47
iShares S&P Mid-Cap 400 Value ETF (IJJ)
is a Sell
Is iShares S&P Mid-Cap 400 Value ETF a Buy, Sell or Hold?
- The current iShares S&P Mid-Cap 400 Value ETF [IJJ] share price is $123.15. The Score for IJJ is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
- IJJ is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
14
Intra-Cellular Therapies (ITCI)
is a Sell
Is Intra-Cellular Therapies a Buy, Sell or Hold?
- The current Intra-Cellular Therapies [ITCI] share price is $73.21. The Score for ITCI is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
- ITCI is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
IJJ Stock Price Chart
What is iShares S&P Mid-Cap 400 Value ETF's stock price today?
-
The iShares S&P Mid-Cap 400 Value ETF share price today is $123.15
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IJJ is experiencing slight selling pressure.
ITCI Stock Price Chart
What is Intra-Cellular Therapies's stock price today?
-
The Intra-Cellular Therapies share price today is $73.21
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ITCI is experiencing selling pressure, which indicates risk of future bearish movement.
IJJ Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.15 | Buy |
Relative Strength Index (14 RSI): | 58.47 | Buy |
Chaikin Money Flow: | -20503 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (118.95 - 123.19) | Buy |
Bollinger Bands (100): | (113.81 - 120.67) | Buy |
ITCI Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.07 | Buy |
Relative Strength Index (14 RSI): | 42.52 | Sell |
Chaikin Money Flow: | -234523 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (73.04 - 75.68) | Sell |
Bollinger Bands (100): | (68.39 - 76.99) | Buy |
IJJ Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 123.05 | Buy |
20-day SMA: | 120.95 | Buy |
50-day SMA: | 119.61 | Buy |
200-day SMA: | 114.98 | Buy |
8-day EMA: | 122.59 | Buy |
20-day EMA: | 121.41 | Buy |
50-day EMA: | 119.62 | Buy |
200-day EMA: | 114.71 | Buy |
ITCI Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 75.4 | Sell |
20-day SMA: | 74.45 | Sell |
50-day SMA: | 75.51 | Sell |
200-day SMA: | 70.84 | Buy |
8-day EMA: | 74.91 | Sell |
20-day EMA: | 74.89 | Sell |
50-day EMA: | 74.57 | Sell |
200-day EMA: | 70.13 | Buy |
iShares S&P Mid-Cap 400 Value ETF Earnings Growth & IJJ Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.38 per share, an increase next quarter of $0.23 per share, an increase this year of $0.97 per share, and an increase next year of $1.07 per share.
iShares S&P Mid-Cap 400 Value ETF Technical Analysis
Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Intra-Cellular Therapies Technical Analysis
Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |